| Mr Lance Stephens, PA-C | |
|
1321a Interstate Pkwy, Augusta, GA 30909-5626 | |
| (706) 738-7246 | |
| (706) 738-7248 |
| Full Name | Mr Lance Stephens |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant |
| Experience | 15 Years |
| Location | 1321a Interstate Pkwy, Augusta, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245522473 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208VP0000X | Pain Medicine - Pain Medicine | 10373 (Georgia) | Secondary |
| 363AM0700X | Physician Assistant - Medical | 10373 (Georgia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Augusta Pain Consultants, Pc | 0648277533 | 5 |
News Archive
Scientists from the Barbara Ann Karmanos Cancer Institute and Wayne State University School of Medicine (WSU SOM) in Detroit will present the world's largest study that shows the long-term results of fast neutron radiotherapy (FNRT) in the treatment of localized prostate cancer. The findings will be formally announced Tuesday, Nov. 2, at the American Society of Therapeutic Radiology and Oncology (ASTRO) Annual Meeting
HCA Healthcare UK has announced the launch of CAR T-cell therapy - a ground-breaking new blood cancer treatment which will be available to eligible patients with Diffuse Large B-Cell Lymphoma and Acute Lymphoblastic Leukaemia.
TVG is pleased to welcome leading biotech and pharma executives at the 18th Annual BioPartnering Europe, held in London, UK. To open the conference, Dr. Anders Ekblom, Executive Vice President, Global Medicines Development at AstraZeneca, spoke about a commitment to innovation and AstraZeneca's unique approach to collaborations.
Independent groups plan to emphasize abortion and other issues in television and radio advertisements, fundraising appeals and direct mail campaigns leading up to the Maryland U.S. Senate elections on Nov. 7, the Washington Post reports.
The most comprehensive search to date of DNA abnormalities in chronic lymphocytic leukemia (CLL) has unearthed several new altered genes that drive this common blood cancer, a finding that could potentially help doctors predict whether an individual patient's disease will progress rapidly or remain indolent for years, say scientists from Dana-Farber Cancer Institute and the Broad Institute.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Lance Stephens, PA-C 1321a Interstate Pkwy, Augusta, GA 30909-5626 Ph: (910) 574-0573 | Mr Lance Stephens, PA-C 1321a Interstate Pkwy, Augusta, GA 30909-5626 Ph: (706) 738-7246 |
News Archive
Scientists from the Barbara Ann Karmanos Cancer Institute and Wayne State University School of Medicine (WSU SOM) in Detroit will present the world's largest study that shows the long-term results of fast neutron radiotherapy (FNRT) in the treatment of localized prostate cancer. The findings will be formally announced Tuesday, Nov. 2, at the American Society of Therapeutic Radiology and Oncology (ASTRO) Annual Meeting
HCA Healthcare UK has announced the launch of CAR T-cell therapy - a ground-breaking new blood cancer treatment which will be available to eligible patients with Diffuse Large B-Cell Lymphoma and Acute Lymphoblastic Leukaemia.
TVG is pleased to welcome leading biotech and pharma executives at the 18th Annual BioPartnering Europe, held in London, UK. To open the conference, Dr. Anders Ekblom, Executive Vice President, Global Medicines Development at AstraZeneca, spoke about a commitment to innovation and AstraZeneca's unique approach to collaborations.
Independent groups plan to emphasize abortion and other issues in television and radio advertisements, fundraising appeals and direct mail campaigns leading up to the Maryland U.S. Senate elections on Nov. 7, the Washington Post reports.
The most comprehensive search to date of DNA abnormalities in chronic lymphocytic leukemia (CLL) has unearthed several new altered genes that drive this common blood cancer, a finding that could potentially help doctors predict whether an individual patient's disease will progress rapidly or remain indolent for years, say scientists from Dana-Farber Cancer Institute and the Broad Institute.
› Verified 7 days ago